Ben Franklin TechVentures-based Saladax Biomedical Inc., a diagnostics company providing kits to test drug blood levels for adherence and personalized dose management, will launch of a new line of tests for psychiatry in Europe (CE mark) with tests for: clozapine, quetiapine, aripiprazole, risperidone, olanzapine, and paliperidone. These are the most commonly used antipsychotic medications. The MyCare Psychiatry™ panel of tests addresses a critical, unmet need for quickly identifying levels of antipsychotic drugs in a patient’s body. A one-hour turnaround time is possible. More: https://bit.ly/2JUu0bm
Client & Alumni News
Saladax Launches Game-Changing Assays for Psychotherapeutics in Europe
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.